The development of a therapy application is complex: It starts as an idea in research and development, goes through preclinical and clinical studies until market approval and commercialization are achieved.

During this process the shift from RUO to GMP is a quality necessity but it is difficult to change key parameters like raw materials when a documented process is already established. Therefore, it is advisable to switch as early as possible to optimize costs and save valuable time. This transition process is crucial to ensure product safety and efficacy, meets regulatory requirements, and ultimately, to secure market approval. We support you during the development from research to commercialization with our media, reagents and buffer solutions, which support a seamless transition with three perfectly tuned quality grades.